key: cord-0808449-6lmf4dhc
authors: Kalia, Inderjeet; Anand, Rajesh; Quadiri, Afshana; Bhattacharya, Shreya; Sahoo, Bijayalaxmi; Singh, Agam Prasad
title: Plasmodium berghei-Released Factor, PbTIP, Modulates the Host Innate Immune Responses
date: 2021-12-07
journal: Front Immunol
DOI: 10.3389/fimmu.2021.699887
sha: 7665940691711f2208ae0f351175fc72f482a871
doc_id: 808449
cord_uid: 6lmf4dhc

The Plasmodium parasite has to cross various immunological barriers for successful infection. Parasites have evolved mechanisms to evade host immune responses, which hugely contributes to the successful infection and transmission by parasites. One way in which a parasite evades immune surveillance is by expressing molecular mimics of the host molecules in order to manipulate the host responses. In this study, we report a Plasmodium berghei hypothetical protein, PbTIP (PbANKA_124360.0), which is a Plasmodium homolog of the human T-cell immunomodulatory protein (TIP). The latter possesses immunomodulatory activities and suppressed the host immune responses in a mouse acute graft-versus-host disease (GvHD) model. The Plasmodium berghei protein, PbTIP, is expressed on the merozoite surface and exported to the host erythrocyte surface upon infection. It is shed in the blood circulation by the activity of an uncharacterized membrane protease(s). The shed PbTIP could be detected in the host serum during infection. Our results demonstrate that the shed PbTIP exhibits binding on the surface of macrophages and reduces their inflammatory cytokine response while upregulating the anti-inflammatory cytokines such as TGF-β and IL-10. Such manipulated immune responses are observed in the later stage of malaria infection. PbTIP induced Th2-type gene transcript changes in macrophages, hinting toward its potential to regulate the host immune responses against the parasite. Therefore, this study highlights the role of a Plasmodium-released protein, PbTIP, in immune evasion using macrophages, which may represent the critical strategy of the parasite to successfully survive and thrive in its host. This study also indicates the human malaria parasite TIP as a potential diagnostic molecule that could be exploited in lateral flow-based immunochromatographic tests for malaria disease diagnosis.

Malaria is a debilitating infectious disease in vertebrates, including humans, and is transmitted through the bites of the Plasmodium carrier Anopheles mosquitoes. In 2019, approximately 229 million malaria cases were reported, with about 409,000 deaths, and these figures will likely shoot up due to the recent coronavirus outbreak, restricting mosquitoes and parasite control measures (1, 2) . Natural immunity against malaria is crucial to protect the host from the severe form of the disease and anemia (3) . Natural immunity develops in a population of a malaria-endemic area by repeated Plasmodium exposure for many years through mosquito bites. However, it does not provide sterile protection against the disease; also, it is short lived and fades away quickly (3, 4) . Immune responses against blood-stage parasites are complex and possibly initiated when parasite-derived glycosylphosphatidylinositol (GPI), DNA, and metabolic products (e.g., hemozoin and uric acid) are released during the blood stage of malaria infection (5) (6) (7) (8) . These parasite-derived products are sensed by Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-like receptors containing pyrin domain 3 on dendritic cells (DCs) and macrophages and lead to the activation of CD4 + and CD8 + T cells, as well as parasite-specific antibodies to contain the bloodstage infection (9) (10) (11) . However, observational studies have suggested that the human malaria parasite always persists for several weeks or months and that immunity to malaria develops slowly, indicating that the parasite may have developed strategies to suppress the host immune responses in order to thrive in the host (12) . Previous studies have suggested that the malaria parasite can inhibit the activation of parasite-specific CD4 + Tcell responses by inducing the apoptosis of DCs, downregulating co-stimulatory molecules, and/or suppressing antigen presentation by DCs (13) (14) (15) . The Plasmodium parasite also induces apoptosis and anergy of the activated CD4 + T and B cells (16) (17) (18) . Observational studies in mice and humans have suggested the role of natural regulatory T cells (Tregs) in malaria infection and the presence of increased Tregs during the infection (19, 20) . However, the mechanisms of host immune manipulation by the parasite remain poorly understood.

The manipulation of host immune pathways by parasites involving active discharge of molecules, analogous to host cytokines, has recently been reported during malaria infection (21) . The Plasmodium parasite-released homolog of the mammalian migration inhibitory factor (MIF) induces antigenexperienced CD4 + T cells into short-lived effector cells rather than memory cells through binding on its CD74 receptor in DCs and macrophages during blood-stage malaria (22, 23) . Such ability of pathogens to circumvent the host defense mechanisms is also evident in bacterial infection and chronic infection of filarial worms and schistosomes (24, 25) . In nematodes, immune evasion strategies promote the survival of parasites within the host by altering the activation of the host immune responses during infection. The worm-secreted/ excreted products such as serpins, miRNA, and proteases are capable of mimicking host molecules to carry out immune modulation in the host (25, 26) . Various reports highlight such ability of the parasites to circumvent the host anti-parasitic responses, and this understanding is critical in designing therapeutic interventions.

Here, we report that the malaria parasite expresses a T-cell immunomodulatory protein (PbTIP) on the surface of merozoites that is homologous to human T-cell immunomodulatory protein (TIP). TIP was shown to have a protective role in a mouse model of graft-versus-host disease (GvHD) by manipulating T-cell responses (27) . The Plasmodium berghei homolog of TIP, PbTIP, is exported on the infected erythrocyte surface upon infection by merozoites. Fragmentation of the surface-expressed P. berghei PbTIP, likely by protease(s), resulted in its shedding from the red blood cell (RBC) surface into host circulation. Once in circulation, PbTIP exhibited binding on host macrophages and reduced the expressions of their inflammatory cytokine genes while upregulating the expressions of the Th2-type/anti-inflammatory cytokine genes. PbTIP also helps in parasite growth in vivo.

A Plasmodium Hypothetical Protein Is Homologous to Human T-Cell Immunomodulatory Protein BLAST searches of human TIP (Q8TB96) across species showed homology with a hypothetical Plasmodium falciparum protein, Q8I3H7, and both proteins shared 29.6% homology along the protein length (28) . SMART domain analysis (Simple Modular Architecture Research Tool; http://smart.embl-heidelberg.de/) (29) revealed a conserved domain organization in human TIP and Q8I3H7, both containing transmembrane (TM) helices at similar locations. It also revealed the presence of the VCBS domain (pfam13517) ( Figure 1A) , which is found in several copies in long proteins in many species of Vibrio, Colwellia, Bradyrhizobium, and Shewanella, hence named VCBS. The suggested role of the VCBS domain is in cellular adhesion (30, 31) . Through homology searches, we also found that P. falciparum Q8I3H7 is orthologous to an uncharacterized P. berghei protein, sharing 71.9% homology (query cover = 92%, e-value = 0.0). Human TIP also shares 27.88% homology with this P. berghei protein; hence, we called it PbTIP ( Figure 1B) . PbTIP also shares 28.33% homology with mouse TIP (Q99KW9.2). P. falciparum Q8I3H7 is not only an ortholog of PbTIP; rather, other orthologs of this protein are present across all Plasmodium species. No paralogs of this protein could be found in respective Plasmodium species (32) .

The adhesion property of human TIP and PbTIP is envisaged by the presence of seven FG-GAP repeats, which is characteristic of integrin-a. The FG-GAP repeats also contained a conserved calcium-binding motif (D-x-N/D-x-D-xxx-D), and these repeats were shown to have importance in ligand binding (33, 34) ( Figure 1B) . A putative epidermal growth factor (EGF)-like domain is also present in PbTIP, which aligned well with mouse EGF and the EGF-like domain of the P. berghei protein, MSP1 (merozoite surface protein 1) ( Figure 1C) . Plasmodium proteins containing an EGF-like domain have already been shown to mediate adhesion through this domain. The RGD motif (arginine-glycine-aspartic acid, a tripeptide motif that mediates adhesion in extracellular matrix proteins such as fibronectin, vitronectin, and laminin) in the EGF-like domain also strongly correlates with its role in adhesion (35) . The existence of a VCBS domain in PbTIP further strengthens its role in adhesion as the VCBS domain is implicated in cellular surface binding, as reported in various bacteria (30) ( Figure 1B and Supplementary Figure S1 ). All the predicted domains of PbTIP are summarized in Figure 1A .

PbTIP Localizes to the Surface of Infected Erythrocytes TMHMM 2.0 (the transmembrane helix prediction tool; http://www. cbs.dtu.dk/services/TMHMM/) (36) analysis of the P. berghei TIP (PbANKA_124360.0) amino acid sequence revealed the presence of two TM helices, one at each terminus ( Figure 2A) . Moreover, Parker's hydrophilicity tool also predicted two hydrophobic stretches in PbTIP that correspond to two predicted TM helices at both termini ( Figure 2B ). The intervening part of the protein between two TM regions is likely extracellular and represents the ectodomain part of the protein ( Figure 1B, dashed box) .

Bacterially expressed recombinant PbTIP was used for mouse and rat immunizations in order to raise immune sera against the protein. Immune serum was used to localize PbTIP in the parasite by performing immunofluorescence assays (IFAs). Our results suggest that PbTIP was expressed on the surface of merozoites. Immunostaining images demonstrated that the A B C FIGURE 1 | A hypothetical Plasmodium protein is homologous to human T-cell immunomodulatory protein (TIP) and is predicted to contain various putative adhesion domains. (A) Summary of the various putative domains in the Plasmodium berghei TIP. (B) The PbANKA_124360.0 encoded protein designated as PbTIP shared 27.88% and 28.33% homology with human TIP and mouse TIP, respectively, along their lengths. PbTIP is predicted to contain two transmembrane (TM) helices [7-29 and 662-681 amino acid (AA) positions, outlined in pink], leaving behind small intracellular stretches at both ends, and most part of the protein is extracellular (enclosed in a dashed box). Seven atypical calcium-binding motifs (yellow boxes) were present at regular intervals in the extracellular part of the PbTIP containing the conserved D-x-N/D-x-D-xxx-D sequence. The VCBS (Vibrio, Colwellia, Bradyrhizobium, and Shewanella) domain was also present and encompassed the third and fourth calcium binding motifs (highlighted in blue). "*" indicates perfect alignment. Mutiple stars **, ***, ****, ***** are repetition of same marking and has same meaning as the single star. ":" indicates a site belonging to a group exhibiting strong similarity. "." indicates a site belonging to a group exhibiting weak similarity. A putative epidermal growth factor (EGF)-like domains (shaded black) containing the RGD (arginine-glycine-aspartic acid) motif was also present between the fifth and sixth calcium-binding motifs. (C) The PbTIP putative EGF-like domain aligns well with the mouse EGF and MSP1 of P. berghei, and these domains are well known to play an adhesion role in many Plasmodium proteins. The RGD motif further strengthens its role in adhesion.

protein localized to the merozoite surface, similar to MSP1, which is a known merozoite surface protein. Although its surface expression was not uniform like MSP1, it was abundant at the one end of merozoites ( Figure 2C and Supplementary Figure S2) . PbTIP was also expressed in packed merozoites inside a schizont as a surface protein, clearly marking boundaries ( Figure 2D) .

Immunostaining of parasitized blood smear upon its permeabilization revealed that PbTIP was localized to the parasitophorous vacuolar (PV) membrane and within the infected erythrocyte cytosol. PbTIP was exported from the parasite into the host cell cytoplasm and surface, as exhibited by the immunostaining assay ( Figures 3A, B) . Intra-erythrocytic staining revealed the punctate pattern of PbTIP in the ring and trophozoite stages of P. berghei. PbTIP was also expressed in the gametocyte stage, and its expression was much higher in gametocytes compared to that in the asexual blood stages of P. berghei ( Figure 3A , bottom panel).

When immunostaining was performed on a non-permeabilized infected blood smear, it showed PbTIP expression on the surface of infected RBCs. The co-localization of band 3 (a RBC membrane marker) and PbTIP indicated that this protein decorated the surface of infected host cells ( Figure 3B ). To be localized on the surface of erythrocytes, PbTIP would have been exported across parasite confinement within the cell. The protein traversed the PV membrane and the host cytoplasm in order to reach the surface (Supplementary Figure S3) . However, the amino acid sequence of PbTIP did not show any identifiable Plasmodium export element (PEXEL) motif to facilitate its export, suggesting that it may be a PEXEL-negative exported protein (PNEP) (37) . Figure 4A . MSP1 (a merozoite surface protein) did not exhibit protein shedding, indicating that only some surface proteins were shed, which included PbTIP (Supplementary Figure S4) . However, the mechanism of this shedding is unknown, and it is possibly executed by the cleavage of the membrane-anchored PbTIP by proteases similar to rhomboid protease (38, 39) . The shedding of PbTIP into host circulation is likely executed by its fragmentation, as multiple fragments of protein were detected in the parasite blood-stage lysate when subjected to electrophoresis and Western blotting. Uncleaved PbTIP was detected at~77 kDa, while multiple fragments of it were detected at various sizes, viz.~70,~50, and~25 kDa ( Figure 4B ). Recombinant PbTIP also exhibited cleavage and resulted in protein fragments of similar sizes in Escherichia coli A B FIGURE 3 | Plasmodium berghei T-cell immunomodulatory protein (PbTIP) was exported across the parasitophorous vascular membrane (PVM) and into the infected surface of host erythrocytes. (A) Immunostaining of permeabilized P. berghei blood stages with antibodies (polyclonal sera) against the target protein revealed PbTIP expression in its various forms. Intra-erythrocytic PbTIP staining revealed its presence in the cytoplasm of host cell. Yellow arrows represent the PbTIP in the cytosol of host cell in a punctate pattern. To demonstrate the export here, PVM is marked with red arrows (DIC panels) and the presence of PbTIP beyond the PVM marked as the exported protein. Moreover, EXP1 (a known parasite PVM protein) and PbTIP co-staining clearly demonstrated its export across the PVM in infected red blood cells (RBCs) (Supplementary Figure S3 ). PbTIP is also localized to the PVM in the ring and trophozoites stages. PbTIP expression in mature gametocytes was much higher compared to that in the ring and trophozoite stages. Permeabilization of blood smears was performed with 0.2% saponin, as described in Materials and Methods. (B) The export of PbTIP into the surface of infected RBCs was demonstrated by performing immunostaining on nonpermeabilized cells. PbTIP (red fluorescence) can be seen clearly displayed on the infected surface of RBCs as a ring that co-localizes with band 3 (green fluorescence), which is one of the most abundant membrane proteins of erythrocytes. Band 3 antibodies were used to mark the surface of erythrocytes. This representative image was taken from more than 50 similar images. DAPI staining was used to locate the nucleus of the parasite. Scale bar, 5 µm. The boundaries of infected host cells are marked with white arrows. These representative images were taken from more than 30 similar microscopy images. Scale bar, 10 µm. (B) Probing with anti-PbTIP antibodies in the blood-stage parasite lysate revealed the fragmentation of PbTIP into multiple smaller fragments. This fragmentation, by an uncharacterized process, is likely responsible for the shedding of the protein from the surface of erythrocytes. Full-length PbTIP was observed at~75 kDa, and its two major fragments were observed at~50 and~25 kDa. (C) Shed PbTIP was detected in the infected host blood sera using sandwich ELISA, with healthy mouse sera as a negative control (black bars). PbTIP could be detected in the host circulation up to 128-fold dilution of the blood sera (red bars). Error bars represent the standard deviation of the mean absorption at 370 nm optical density (OD). The data presented are from three replicates performed. (D) Fragments of shed PbTIP (~25-30 kDa) detected by Western blotting of infected mouse serum, with healthy mouse serum as a negative control. (E) Detection of the released PbTIP in the P. berghei culture medium harvested at various time points. Parasite culture was set from infected mouse blood containing mostly trophozoite stages, and the spent culture medium was harvested at various time points as described in the figure and sandwich ELISA performed as described in the Materials and Methods. In in vitro conditions, PbTIP shedding was not optimum. Only a non-significant (ns) increase in the shed PbTIP levels post-schizont bursting (at 6 and 27 h) was observed. Fresh culture medium, RPMI, was used as the negative control in the ELISA. Schizont bursting was ascertained by Giemsa staining of a cultured schizont smear. (F) For comparison purposes, we detected shed PbTIP in infected mouse serum again using sandwich ELISA and observed that shedding was significantly higher in in vivo conditions (p = 0.00014 and 4.39E−05, respectively). The x-axis represents the dilution of serum used in the ELISA, i.e., at 1:2 and 1:6 ratios. Uninfected mouse serum was used as the negative control in ELISA. The mice used for both studies had identical parasitemia. "****" denotes the P value less than 0.00005 to 0.00001 and ns means not significant. Figure S5A) , and PbTIP cleavage was not due to a proteolytic cleavage during the purification process. However, the mechanism of PbTIP cleavage and the protease(s) involved are still unknown. Protein sequencing of one of the major E. coli-expressed PbTIP fragments (~55 kDa) pointed at the presence of one of the cleavage sites near its N-terminus (Supplementary Figure S6 and Table S1 ).

Shed PbTIP was also detected in the serum collected from malaria-infected mouse with indirect sandwich ELISA using antibodies against this protein. We detected PbTIP even up to a 128-fold dilution of the infected mouse serum ( Figure 4C ). Serum from uninfected mice was taken as a negative control in the ELISA. Moreover, the infected host sera, when subjected to electrophoresis followed by immunoblotting with antibodies against PbTIP, showed~25-to 30-kDa sized fragments of PbTIP, while no band was observed in healthy mouse serum ( Figure 4D ). These bands likely originate from the cleaved fragments of the surface-anchored extracellular domain of the PbTIP. To address the critical aspect of PbTIP shedding, which is the time of its release, we interrogated by culturing P. berghei in vitro and collecting the spent medium at various time points in order to detect shed PbTIP in it using ELISA. Our results indicated that, in culture conditions, the PbTIP level did not significantly change over the entire time course (one complete cycle of growth), suggesting that PbTIP shedding is not optimal in the in vitro conditions ( Figure 4E) . A non-significant enhancement in shed PbTIP in the culture medium was observed during the schizont stage (6 and 27 h post-culture). However, the in vitro results significantly differed from our in vivo data, where we detected a significant amount of shed PbTIP in the serum collected from infected mice ( Figure 4F ), indicating that, somehow, shedding has a comparatively high feasibility in vivo than in in vitro conditions.

In brief, our results indicated that PbTIP shedding is not optimal in culture conditions, while a significant amount of PbTIP could be detected in in vivo conditions. Our immunostaining images also indicated that schizont rupture events did not contribute significantly to the release of PbTIP into the surroundings (Supplementary Figure S7 ).

The adhesion properties of PbTIP in host circulation were evident in vitro by incubating recombinant PbTIP (10 µg/ml) with murine origin macrophages, RAW 264.7 cells ( Figure 5A , top panel). This binding is in concordance with various adhesion domains in PbTIP (FG-GAP domains, RGD motif, VCBS domain, and EGF-like domain), which may affect binding on host cells (30, 35) . PbTIP binding on the surface of macrophages was further confirmed by incubating the sera of infected mice containing parasite-shed PbTIP with RAW 264.7 cells ( Figure 5A , middle panel). Parasite bloodstage lysate (obtained by freeze-thaw lysis) containing various fragments of PbTIP also displayed binding on macrophages ( Figure 5A , bottom panel). The binding was further confirmed using mouse peritoneal macrophages that demonstrated the surface binding of PbTIP on macrophages ( Figure 5B ). Pre-immune serum of mice was used in negative controls while performing IFAs.

To study the immunomodulatory effect of PbTIP upon its binding to host macrophages, we stimulated RAW 264.7 cells with E. coli lipopolysaccharide (LPS) in the presence and absence of recombinant PbTIP. LPS is a well-known immune stimulus recognized through TLR4 present on the surface of macrophages leading to the activation of multiple signalling components, such as NF-kB and IRF3, and the subsequent production of Th1-type pro-inflammatory cytokines. In this section, the LPS-elicited immune responses of RAW 264.7 cells are described in the presence and absence of recombinant PbTIP. We stimulated RAW 264.7 cells with E. coli LPS (100 ng/ml) alone or in combination with recombinant PbTIP, and buffer (50 mM Tris, 150 mM NaCl, and 10% glycerol) alone was used as a negative control. LPS stimulation of RAW 264.7 cells for 9 h resulted in increased messenger RNA (mRNA) expression levels of the pro-inflammatory cytokines, which included interleukin 1b (IL-1b), IL-12, interferon gamma (IFN-g), and tumor necrosis factor alpha (TNF-a). However, the levels of pro-inflammatory cytokines were reduced significantly when RAW 264.7 cells were treated with a combination of LPS and PbTIP (10 µg/ml). The expression levels of cytokines were validated with quantitative PCR (qPCR) (performed in triplicate) at the transcript level, and the C t values obtained were analyzed to calculate the relative fold change using the 2 −DDCt method. The transcript levels of IL-1b, TNF-a, IFN-g, and IL-12p40 were reduced by 6-, 15-, 2.6-, and 3-fold, respectively ( Figure 5C) .

Furthermore, the stimulation of RAW 264.7 cells in a similar fashion for a longer duration, i.e., 20 h (40), resulted in the upregulation of Th2-type/anti-inflammatory cytokine transcripts while suppressing the inflammatory cytokine transcripts. The mRNA expression levels of TGF-b and IL-10 were upregulated by five and ninefold, respectively ( Figure 5D ). The cytokine transcript levels were validated by qPCR and analyzed in a similar manner (as in Figure 5C ) to calculate the relative fold change. Details of the primers and their references are provided in Supplementary Table S2 .

Furthermore, cytokines were also estimated in the cell culture medium (spent medium) of the LPS-elicited RAW 264.7 cells in the presence and absence of recombinant PbTIP at respective time points through ELISA. Our results indicated that the expressions of the pro-inflammatory cytokines were suppressed significantly while those of the anti-inflammatory cytokines were found significantly upregulated in the study, conveying the same notion of immunosuppression and inducing Th2 responses in macrophages upon exposure to PbTIP (Supplementary Figure S8 ).

The in vivo effect of recombinant PbTIP on parasite growth was established by injecting this protein (2 mg/kg, day 1 onwards). The experimental design, number of doses, and the amount injected were all similar to those published by Fiscella et al. (27) . Mice (n = 8 per group) were infected with 2 × 10 5 P. bergheiinfected RBCs given intravenously on day 2. After four consecutive daily doses of recombinant PbTIP, we observed accelerated parasite growth in treated mice when compared with the control group ( Figure 6A (ii)). Parasitemia was determined by staining thin blood smears with Giemsa stain and counting the parasites per 100 RBCs using a light microscope. At least 2,000 RBCs were counted for each slide. On day 5, the parasitemia in the treated group was almost twofold higher than that in the control group. Moreover, recombinant PbTIP-injected mice died 1 day earlier, as shown in Figure 6A (iii). The immunosuppressive effects of PbTIP, as evident in vitro on host macrophages ( Figures 5C, D) , was further explored in vivo. The systemic effect of PbTIP on various host responses was studied by treating healthy C57BL/6 mice with recombinant PbTIP (2 mg/kg) for four consecutive days, followed by peripheral blood mononuclear cell (PBMC) isolation and transcriptome analysis. Glutathione S-transferase (GST) protein-injected mice were taken as control. Next-generation sequencing (NGS) data analysis revealed 51 upregulated and 3 downregulated genes (Supplementary Table S3 ).

Many of the differentially expressed genes have direct relevance to this study, and some of them are described here ( Figure 6B (ii) and Supplementary Figure S9 ). Upon PbTIP exposure, Arl5b, which is a negative regulator of MDA5dependent immune response, was upregulated, and its overexpression repressed the MDA5-induced activation of the interferon-b promoter (41) . The B-and T-lymphocyte attenuator (BTLA) was another upregulated gene upon PbTIP exposure, which behaved like PD1 and CTLA-4. BTLA displayed T-cell inhibition and was also a negative regulator of B-cell proliferation (42) . Upregulation of ATM (serinethreonine kinase) in immune cells may cause apoptosis of monocytes. Atrx and Caprin2 were also upregulated and reported to be linked with apoptotic pathways (43, 44) . Genes such as Cacna1e and FLT1 were also significantly upregulated under cancerous conditions, and evidence suggests that these genes could be crucial factors for the macrophage M2 phenotype in the tumor microenvironment (45, 46) . Such macrophages display skewed immune responses toward M2type/anti-inflammatory response. Conversely, Ece1, involved in the proteolytic processing of endothelin 1 peptide and produced by the macrophages in response to microbial stimulation, was downregulated. Another downregulated gene, Arhgap22 (a rho GTPase), has been reported essential in lamellipodia formation in macrophages, and its downregulation may affect the migration of macrophages upon PbTIP exposure (47) . A few of the differentially regulated genes selected based on transcriptome data were validated by qPCR (Supplementary Figure S10) . The qPCR results concur with the transcriptome data. Primer details are provided in Supplementary Table S2.

The real success of parasites in their host is majorly attributed to their ability to subvert the anti-parasitic host immune responses (48) . In higher vertebrates, the immune system has evolved to recognize a vast array of foreign invaders in order to facilitate their elimination (49) . On the other hand, pathogens have developed various immunomodulation strategies to effectively manipulate host responses and thrive successfully in their host (12, 25) . For example, mouse malaria is characterized by the production of proinflammatory cytokines in the early phase of the infection and a reduced cytokine response in the face of continuing infection. Dendritic cells has also become less responsive to TLR-mediated IL-12 and TNF-a production while enhancing their ability to produce the immunosuppressive cytokine IL-10 (14) . During the later stages of malaria infection, host immunity becomes refractory not only to Plasmodium antigens but also to unrelated antigens (50) . Immunomodulation by host molecular mimics has been reported during viral infections and is crucial during Plasmodium infection (51) . Plasmodium-released host-like molecules, such as PMIF (Plasmodium macrophage migration inhibitory factor) and TCTP (translationally controlled tumor protein homolog of host histaminereleasing factor), have already been proven to manipulate the host immune responses for the benefit of the parasite (22, 52) .

In the search of parasite molecules homologous to their host, we came across a T-cell immunomodulatory protein (TIP) that is conserved in Plasmodium species and shares homology with human TIP in its topology and domain structures (28) . The Parasite blood-stage lysate (obtained from parasite free-thaw lysis) containing various fragments of PbTIP also exhibited binding on RAW 264.7 cells (bottom left panel). Images were taken at ×200 magnification on a Zeiss Axio imager M2 microscope. DAPI was used to stain the nuclei of cells. Scale bar, 10 µm. (B) Recombinant PbTIP binding upon incubation with murine peritoneal macrophages and RAW 264.7 cells. Images were taken at a higher magnification to unveil surface binding of PbTIP. Scale bar, 10 µm (top panel) and 5 µm. Glutathione S-transferase (GST) protein was used as a negative control for binding. (C) PbTIP surface binding reduced the ability of macrophages to mount inflammatory responses upon lipopolysaccharide (LPS) stimulation: (i) IL-1b was reduced by sixfold; (ii) TNF-a was reduced by 15-fold; (iii) IFN-g was reduced by 2.6-fold; (iv) IL-12p40 was reduced by threefold. (D) The levels of anti-inflammatory cytokines such as TGF-b and IL-10, however, increased by five and ninefold, respectively, with longer exposure to PbTIP (20 h). The experiment was repeated more than three times, and C t values obtained from quantitative PCR (qPCR) were used to calculate the relative fold change using the 2 −DDCt method. Statistical significance values (pvalues) of the transcript fold change between the LPS-stimulated and LPS+PbTIP RAW 264.7 cells were given for various cytokine genes: for IL-1b, TNF-a, IFN-g, and IL12p40, 0.0032, 0.008, 0.01, and 0.04, respectively. For the anti-inflammatory cytokines, such as IL-10 and TGF-b, the p-values were 0.0002 and 0.004, respectively. Student's t-test was performed to calculate the statistical significance of the data. *, ** and *** signifies p values in the range of 0.05 to 0.01, 0.005 to 0.001 and 0.0005 to 0.0001, respectively. presence of seven loosely conserved FG-GAP domains, including the conserved Ca + -binding motifs such as integrins of metazoans, suggests its role in adhesion. Reports suggested that these seven FG-GAP domains may fold into a seven-bladed betapropeller structure that serves as its ligand-binding domain.

PbTIP is also conserved in metazoans from placozoa to vertebrates, including humans (53) . PbTIP to study its effect on parasite growth. The recombinant P. berghei protein was intraperitoneally injected (2 mg/kg) into C57BL/6J mice (n = 8) for four consecutive days. Infection was initiated on day 2 and daily parasitemia was followed post-infection. (ii) Injection of recombinant PbTIP in malaria-infected mice accelerated parasite growth, as estimated by monitoring daily parasitemia. On day 6 postinfection, parasitemia was approximately twofold higher in PbTIP-treated mice. Glutathione S-transferase (GST) protein-injected mice were taken as the control since recombinant TIP has a GST fusion partner. The experiment was repeated more than three times. Student's t-test was performed to evaluate the significance of the data (the p-values on days 3, 4, 5, and 6 were 0.038, 0.01, 0.0003, and 2.91E−08, respectively, suggesting significant differences in parasitemia between the two groups).

(iii) Recombinant PbTIP-treated mice also showed early death compared to control-treated mice. However, it was not found to be statistically significant using the logrank test (p > 0.05). (B) (i) Systemic effect of PbTIP on host responses was studied by treating C57BL/6J mice with recombinant PbTIP (2 mg/kg) for four consecutive days, followed by peripheral blood mononuclear cell (PBMC) isolation and transcriptome analysis. (ii) Volcano plot displaying the differentially expressed genes revealed in the transcriptome analysis, and the genes that may have direct relevance in our study are highlighted as blue dots. Various upregulated genes upon PbTIP exposure are reported to be negative regulators of immune responses (Arl5B, BTLA, and Fbxl3), mediators of apoptosis (ATM, Atrx, and Caprin2), and induced in cancerous conditions (Cacna1e and Flt1). Of the downregulated genes, Arhgap22 may affect the migration of macrophages upon PbTIP exposure. GST protein-treated mouse PBMCs were used as the control in the transcriptome analysis. Black dots represent genes that were not significantly changed in the study (−log10 p < 1.2), while red dots represent the significantly upregulated/downregulated genes (−log10 p > 1.2). The dashed line denotes the cutoff mark for the significance level (−log10 p = 1.2). We used unpaired t-tests assuming unequal variances to calculate the significance values of the genes in the study. *** means p value < 0.0004.

domain organization and protein lengths. However, considering the relatively low homology between Plasmodium TIP and its natural host's mosquito vector and human, the possibility of a recent horizontal gene transfer seems highly unlikely. It could be an old conserved protein that has undergone gradual changes, yet showing homology across the species. As described earlier, PbTIP is conserved among all Plasmodium species; however, no paralogs have been reported, contrary to its host homolog integrins that are organized in multigene families with multiple paralogs (54) .

Here, we report that PbTIP is a surface protein of merozoites in P. berghei similar to MSP1; however, its expression was not uniform all over the surface of merozoites. It was localized abundantly at one end of the merozoites. The presence of two putative TM helices at each terminus further strengthens the PbTIP membrane localization potential. PbTIP was decorated on the surface of infected erythrocytes when merozoites developed into the ring and trophozoite stages. Our data indicated that PbTIP was exported across the PV membrane, although it does not contain any recognizable PEXEL motif to facilitate export. Possibly, it is a PEXEL-negative exported protein, like many other Plasmodium proteins such as MAHRP1, SBP1, and REX2, where the N-terminal TM helix along with the few proximal amino acids are implicated in the export (37) . The PbTIP Nterminal TM helix along with a few amino acids may have facilitated its export in a PEXEL-negative manner. In the ring and trophozoite stages, PbTIP decorated the parasite PV membrane within the infected RBCs, and it was also observed in the host cell cytosol. It could be possible that PbTIP has become part of the PV membrane during its export to the host cell surface. Immunostaining of various asexual stages against PbTIP further revealed that this protein was somehow shed from the surface of parasitized host cells, as we detected it in their surroundings. Protein shedding was seen significantly higher in the mature gametocyte stages. A few well-characterized Plasmodium proteins were shed by protease processing at the cellular surface, and these included AMA1, CSP1, and MSP1 (55, 56) . CSP is known to undergo protease processing and shed during the gliding motility of sporozoites, leaving behind its trails (57) . PbTIP also sheds from the infected host cell surface as its multiple cleaved fragments were observed in the blood-stage parasite lysate with immunoblotting. Fragments of the same size were detected by immunoblotting in every independent experiment, suggesting that fragmentation did not result due to random protease processing. It is possibly cleaved by specific protease(s) that produces the same sized fragments every time.

There could be a variety of proteases involved in PbTIP proteolytic processing and its subsequent shedding; however, the involvement of Plasmodium intramembrane rhomboid proteases is highly anticipated. Various intramembrane proteases have been characterized in Apicomplexa, including Plasmodium species that are implicated in the proteolytic cleavage of integral membrane proteins (58) . The role of rhomboid protease in the shedding of TRAP during sporozoite motility and infectivity has been reported (38) . Similarly, the shedding of AMA1 and MSP1 through the proteolytic activity of rhomboid proteases has been reported earlier. The existence of loosely conserved helix destabilizing residues in the N-terminal TM helix of PbTIP also strengthens our prediction regarding the involvement of parasite rhomboid(s) in its cleavage and the subsequent shedding from the cellular surface (59) . However, some of our findings unveiled that PbTIP shedding is comparatively more feasible in vivo than in cultured conditions, suggesting the involvement of host origin factors in the shedding process. However, no direct evidence is available to support this; the mechanism of proteolysis and the proteases involved remain to be explored.

PbTIP could also be detected in host circulation by immunoassays. In circulation, 25-to 30-kDa protein fragments were more abundant than were other fragments. Furthermore, the presence of TIP (from human malaria parasites) in host circulation could be exploited in the development of malaria rapid antigen testing kits. Plasmodium histidine-rich protein 2 (HRP2), lactate dehydrogenase (pLDH), and aldolase are extensively used for this purpose and pose few advantages over conventional microscopic testing of malaria besides sensitivity (60) . Among all, HRP2 is predominantly used for rapid detection test (RDT) worldwide, but recent reports of HRP2 and HRP3 mutant P. falciparum parasites raised alarm over the search for alternative candidates for the purpose of RDT. The use of purified monoclonal antibodies against PfTIP/PvTIP will surely improve the ELISA sensitivity and bring the detection limit better than that of the present standards.

As described earlier, PbTIP possesses integrin-a domains and various other adhesion domains (VCBS domain, EGF-like domain, and RGD motif). The presence of PbTIP in host circulation directed us to look for the host cells on which it can possibly bind. We tested immune cells firstly as its homolog has already been proven to possess an immune modulation function. PbTIP exhibited binding on macrophages; upon further analysis, we found that it was binding to macrophages of murine origin only. No binding was observed in cells of human origin, suggesting species specificity (data not shown). Furthermore, the PbTIP receptor on macrophages was still elusive and out of the various adhesion domains, which one has affected the binding is still not clear. The receptor for the mammalian TIP is also not yet reported, therefore making it difficult to predict any strong candidate for PbTIP binding.

Since we were more interested in the downstream effects of PbTIP binding on macrophages to establish its possible role in immunomodulation, we tested the inflammatory responses of murine macrophages in the presence of recombinant PbTIP. Exposure of macrophages to recombinant PbTIP suppressed the inflammatory response while it upregulated the Th2-type/antiinflammatory response. Inflammatory cytokines such as IL-1b, IL-6, IL-12p40, TNF-a, and IFN-g were downregulated manifold. On the other hand, the anti-inflammatory cytokines such as IL-10 and TGF-b were upregulated manifold upon protein exposure to PbTIP presence along with E. coli LPS. However, the fold change in cytokines at the transcript level (by qPCR) should not be compared with the corresponding ELISA data (protein level) as the qPCR data displayed the transcript profile of RAW 264.7 cells at the time of harvest while ELISA estimated the total accumulated protein in the spent media. The effect of parasite protein on macrophages leading to altered immune response may have direct relevance to the survival of parasites in the host. EmTIP, a homolog of human TIP in the tapeworm Echinococcus multilocularis, was also present in the excretory/secretory products of the parasite, and it has been shown to stimulate CD4 + T cells in vitro (61) .

It is well established that enhanced levels of TGF-b and IL-10 lead to the increased number of Tregs. In malaria patients, higher levels of Tregs have been reported, which eventually developed tolerance in the host (62) . PbTIP may induce Tregs through IL-10 and TGF-b response by macrophages upon its binding, although it is too early to make such a statement. In the infection setting, macrophages and DCs are the primary cells that detect parasites mounting a pro-inflammatory cytokine response. Inflammation plays three major roles: phagocytosis, antigen presentation, and initiation of immune responses through the production of various cytokines and growth factors (6) . A reduced inflammatory potential upon PbTIP exposure may affect several aspects of macrophages, as explained, although we have not looked into their altered phagocytic activities or antigen presentation, if any. It appears that PbTIP might have affected the NFkB and MAP kinase pathways that LPS activates through TLR-mediated binding to mount an inflammatory response. Reduced inflammatory responses from DCs and macrophages have been reported in murine malaria during the later stage of infection, as described earlier. Such responses from macrophages upon PbTIP exposure seem to cause less Th1-type response while enhancing the ability of target cells to produce Th2-type cytokines. This may induce tolerance in the host in the long term, and the host becomes tolerant not only to parasite antigens but also to unrelated antigens. Recently, two groups [Guha et al., human field data (63), and Nahrendorf et al., mouse model data (64) ] have shown that monocytes from malaria-exposed individuals differentiate into anti-inflammatory M2-type macrophages. Although their views differed on the locations where monocytes changed to the M2 phenotype, both groups agreed that these changes occurred through epigenetic modifications (a decrease in H3K4me3) at the inflammatory cytokine gene loci. The cytokine profile of malariainfected RBC-exposed monocytes, described by Guha et al., largely matches with our data on PbTIP protein-exposed macrophages. Therefore, it is likely that, among the many factors causing monocyte reprogramming by infected RBC, Plasmodium-released PbTIP could be a leading cause.

The in vivo systemic effect of PbTIP on various immune cells was studied in mice treated with recombinant PbTIP, followed by PBMC isolation from the peripheral circulation and transcriptome analysis. The in vitro response of recombinant PbTIP on macrophages should not be compared with its systemic in vivo effect. The interplay of various immune cells and their immune responses cannot be replicated in vitro; hence these studies cannot be directly correlated. Our analysis suggests that PbTIP exposure upregulated the various immune inhibition genes or immune checkpoint pathway genes. Various apoptotic genes were found upregulated, which may have caused apoptosis of responsive immune cells. A few genes that skewed macrophages toward the M2 phenotype were also found differentially expressed upon PbTIP exposure. Mice treated with recombinant PbTIP have enhanced daily parasitemia, suggesting that this protein may affect parasite survival in vivo. Overall, this study suggests an immunosuppressive role of PbTIP in host responses, as evident in the in vitro and in vivo studies. The function of mammalian TIP is still elusive for us to state that parasite PbTIP anyhow mimics the host's TIP function similar to the host MIF mimicked by the Plasmodium-released PMIF. To the best of our knowledge, genetic manipulation in mice has revealed the role of mouse TIP (ITFG2) in the development of Band T-cell responses. Deficient mice showed retention of B cells in the spleen and a lower concentration of immunoglobulin G (IgG) in plasma. It was found essential for the development of a normal germinal center and for adequate humoral response (33) . Hence, as of now, it is very early to make a statement that denotes PbTIP as a functional mimic of host TIP.

In summary, our data suggest that a host-like protein in P. berghei was expressed on the surface of merozoites and exported to the surface of parasitized host cells in the blood-stage infection. By an uncharacterized mechanism, it was cleaved in multiple short fragments that are likely responsible for its shedding from the host cell surface. Shed protein was detected in infected host circulation, and it can be pursued in the development of rapid testing of malaria. The PbTIP shed into host circulation also possessed adhesion properties, exhibited binding on the surface of macrophages, and modulated their inflammatory responses. We report macrophages with reduced inflammatory responses upon PbTIP exposure and the upregulation of Th2 cytokines such as IL-10 and TGF-b. Our in vivo studies also conveyed the same effect of PbTIP on various immune cells. The limitations of our results are that we need to replicate our finding with human malaria parasites and test the TIP of human malaria parasites in order to develop a RDT kit.

Six-to 8-week-old male/female C57BL/6J mice were used in all the animal experiments. All experimental procedures were carried out following Institutional Animal Ethical Committee (IAEC) guidelines (IAEC project approval no. NII/IAEC 535/ 19). To carry out experiments, the animals were first intraperitoneally injected with 150 ml of a ketamine-xylazine mix to induce short-term anesthesia. The P. berghei strains used in this study were obtained from The Malaria Research and Reference Reagent Resource Centre (MR4). Frozen stocks of Pb_ANKA (MRA-671, BEI Resources) or Pb_ANKA-GFPcon (MRA-867, BEI Resources) strains were injected into 6-to 8week-old mice to infect them with malaria. Anopheles stephensi mosquitoes were reared in a humid chamber maintained at 27°C, 70% humidity, and fed on sucrose (20%)-soaked cotton pads. Young female mosquitoes were fed on P. berghei-infected C57BL/6J mice and afterwards maintained at 19-21°C, 70% humidity. On the 18th day after blood feeding, infected mosquitoes again fed on healthy mice to complete the cycle. Sporozoites were obtained by dissecting the salivary glands on the 20th day and then used for in vivo and in vitro infection experiments.

A codon-optimized PbTIP gene fragment (corresponding to 29-660 amino acids) omitting two terminal TM domains was cloned into the E. coli expression vector pGEX6p1, and ligation was facilitated using the BamHI and SalI restriction enzymes (NEB, Ipswich, MA, USA). Details of the primers used for cloning are given in Supplementary Table S3 . The protein was overexpressed in BL21 cells (Stratagene, La Jolla, CA, USA) at 16°C for 15 h with 0.3 mM isopropyl b-d-1-thiogalactopyranoside (IPTG) at OD 600 = 0.8. The recombinant protein was isolated from inclusion bodies by lysing the IPTG-induced bacterial pellet in lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1 mM PMSF, and 10 µg/ml DNase), followed by sonication (amplitude = 30, pulse on = 5 s, pulse off = 10 s) and centrifugation. The supernatant was discarded and the pellet washed three times with wash buffer I (100 mM Tris-HCl, pH 8.0, 5 mM EDTA, 1 mM DTT, 2 M urea, and 2% Triton X-100); the pellet was finally resuspended in solubilization buffer II (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM DTT, and 8 M urea) at room temperature for 3-4 h. The clear supernatant was collected and passed through a 0.45µm syringe filter, followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to check the purity of the protein. Urea was removed by stepwise dialysis, gradually decreasing the urea concentration in the dialysis buffer. No precipitate was observed during dialysis. No columns or purification matrix was used as the inclusion bodies itself gave highly pure protein. Purified protein treatment with Pierce ™ High Capacity Endotoxin Removal Spin Columns (Thermo Scientific, Waltham, MA, USA) resulted in a protein preparation where the endotoxin level was below the recommended limit for animal use. Mice and rats were immunized with recombinant PbTIP as per the standard immunization regimen given in Supplementary Table  S4 . A week after the final immunization, mouse sera were collected and the antibody titer was determined with direct ELISA (Supplementary Figure S7) .

Cells fixed on glass slides were permeabilized (if needed) with 0.2% saponin (Sigma, St. Louis, MO, USA) for 30 min, followed by blocking with 3% bovine serum albumin (BSA). The cells were incubated with primary antibodies (rat anti-PbTIP or mouse anti-PbTIP immune sera) at 500 dilutions overnight, followed by secondary antibodies (anti-rat AF594 or anti-mouse AF488; Abcam, Cambridge, UK) used at 2,000 dilution. Three phosphate-buffered saline (PBS) washes for 5 min each were given after incubations with the primary and secondary antibodies. Slides were mounted in anti-fade (50% glycerol and 2% DABCO; Sigma) and the images taken with a Zeiss AxioImager M2 fluorescence microscope.

Parasite pellets (obtained upon saponin lysis of infected RBCs) were resuspended in 1× PBS and sonicated to separate the soluble and insoluble fractions. The resulting pellet was solubilized in 0.1% SDS containing PBS and centrifuged to obtain the lysate. For Western blot of mouse serum, the excess of albumin protein was removed with AlbuminOut (G-Biosciences, New Delhi, India), followed by SDS-PAGE. The protein from the gel was transferred into a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA), followed by overnight incubation with a blocking buffer (Odyssey). The membrane was probed with a primary antibody (rat anti-PbTIP immune sera, 1/1,000 dilution) for 3 h, followed by an IR-labeled secondary antibody (rabbit anti-rat IR800, 1/10,000 dilution; Invitrogen, Carlsbad, CA, USA) for 2 h. The blot was imaged using the Licor Odyssey imager. For the horseradish peroxidase (HRP)-labeled secondary antibodies, the membrane was incubated with 10 ml of 0.1% 3,3′-diaminobenzidine tetrahydrochloride (DAB; Sigma) containing 12 µl of 30% H 2 O 2 until the band developed.

A high-protein-binding 96-well ELISA plate (Corning, NY, USA) was coated with mouse anti-PbTIP immune sera in coating buffer overnight at 4°C. Serial dilutions of the Plasmodium-infected mouse sera were incubated overnight for binding in cold conditions, followed by incubation with the rat anti-PbTIP immune sera (primary antibodies, 1,000 dilution) for 2 h the next day. The rabbit anti-rat HRP secondary antibody (Novus Biologicals, Englewood, CO, USA) was used at 5,000 dilution for 1 h and developed by adding 100 µl/well of the TMB substrate (Sigma-Thermo Fisher, India), and the absorbance was measured at 370 nm in a Tecan M200 (Theale, Reading, UK) plate reader. In the direct ELISA for estimating the antibody titer, 0.2-0.5 µg/well of the recombinant PbTIP was coated; the rest of the process remained the same.

For cytokine estimation using ELISA, the spent culture medium was collected at 9 and 20 h and 50 µl of the spent medium was used for ELISA following the manufacturer's protocol (BioLegend cat. nos. 432604, 431604, 436707, and 431411; Becton Dickinson cat nos. 560478 and 555138).

C57BL/6J mice infected with P. berghei parasite were humanely sacrificed at 8%-10% parasitemia (mostly trophozoites); the infected blood was collected in heparinized vials. Blood was centrifuged to remove plasma, resuspended in complete RPMI1640 [20% fetal bovine serum (FBS) and 50 mg/L hypoxanthine) media, keeping the hematocrit at 4%-6%, and incubated at 37°C. The culture flasks were flushed with the excess of mixed gas (90% N 2 , 5% CO 2 , and 5% O 2 ) and capped tightly. At regular intervals, the spent culture medium was collected, centrifuged, and kept for ELISA. Schizont formation and their bursting were monitored with Giemsa staining of thin smears of blood culture collected at regular intervals.

Thioglycolate elicited mouse peritoneal macrophages were isolated in ice-cold Dulbecco's PBS and allowed to adhere onto sterile coverslips on a 24-well cell culture plate containing complete RPMI medium (Lonza, Basel, Switzerland). One hour later, the cells were washed with PBS to remove non-adherent cells. Similarly, RAW 264.7 cells were also seeded in a cell culture plate and 10 µg/ml of the recombinant PbTIP was incubated with peritoneal macrophages and RAW 264.7 cells for 1 h. After incubation, the cells were washed with an excess of PBS and fixed with 4% paraformaldehyde (PFA), followed by IFAs to decipher the surface binding of PbTIP.

RAW 264.7 cells were cultured in complete Dulbecco's modified Eagle's medium (DMEM; Lonza) containing 10% FBS (Gibco, Waltham, MA, USA) and seeded into a 24-well cell culture plate. The cells were stimulated with 100 ng/ml of E. coli LPS (Thermo Fisher, India) in the presence and absence of 10 µg/ml recombinant PbTIP for recommended hours. Post-incubation, the RNA was isolated from each well with Trizol (Thermo Fisher, India) following the recommended procedure and 2 µg of the RNA was converted into complementary DNA (cDNA) with an iScript reverse transcription kit (BioRad). qPCR was performed with the gene-specific primers of the various cytokines and a high-efficiency qPCR mix (cat no. 18114R1074; GCC Biotech, West Bengal, India) to calculate the relative fold change (Supplementary Table S3 ). The primers used in the study are given in Supplementary Table S3 .

A group of eight C57BL/6J mice were given four consecutive doses of 2 mg/kg of recombinant PbTIP and their blood collected. An equivalent group of control-treated (GST protein-treated) mice were included in the experiment. PBMCs were isolated with Percoll-based density gradient centrifugation and total RNA was isolated from the purified PBMCs. Briefly, Trizol-preserved samples were stored in −80°C deep freezer until use and then thawed once at the time of RNA extraction. Chilled chloroform was added to one-fifth volume of the Trizol, mixed well, and centrifuged to collect the upper aqueous phase. RNA was precipitated with an equal volume of chilled isopropanol and retrieved by centrifugation at full speed. The RNA pellet was washed with chilled 70% ethanol, air dried, and dissolved in an appropriate volume of nuclease-free water. The RNA integrity number (RIN) was >7 for each sample. A TruSeq (Illumina, San Diego, CA, USA) stranded mRNA library was made using 5 mg total RNA and was sequenced with the Illumina NovaSeq 6000 platform. The paired-end read length was 150 bases. A total of 6 Gb data was collected per sample.

Initial RNA sequence quality assessment was carried out on raw reads using FastQC v0.11. Adapter contamination and lowquality reads (Q < 30) were trimmed out using the NGSQC Toolkit v2.3.3. If 70% of the reads had average good quality (Q ≥ 30), then it was kept and was considered as high-quality (HQ) data. In the next step, HQ reads were assembled using a de novo transcriptome assembly method. The total reads obtained were 37,546,250 and 37,546,250 for the control and 33,346,685 and 33,346,685 for the TIP-treated samples Differential gene expression analysis was carried out using Cuffdiff v2.2.1. The obtained blast hits were then used to annotate the transcripts at different levels, such as pathway and Gene Ontology (GO) annotation, using the Retrieve/ID mapping utility provided by the UniProt database.

Thin blood smears fixed on glass slides (methanol fixed) were stained with a 1:10 times diluted Giemsa staining solution (48900-1L-F; Sigma) in a staining buffer (8 mM KH 2 PO 4 , 6 mM Na 2 HPO 4 , pH 7.0). The Giemsa stain was kept on slides for 30 min, followed by washing the slides under running tap water to remove excess of the stain, and then the slides were air dried for some time. Blood smears were observed under ×100 magnification using oil immersion lens fitted in a Nikon 80i microscope.

Data are presented as the mean and SDs. Statistical analyses were performed using Student's t-test. Statistically significant differences compared with the control are indicated by asterisks: *p < 0.05, **p < 0.01, ***p < 0.001. All the statistical analysis was done in Excel or GraphPad Prism. Survival curve was analyzed by the log-rank test to evaluate its statistical significance.

The datasets presented in this study can be found in online repositories. The names of the repository and accession number can be found below: https://www.ncbi.nlm.nih.gov/, GSE173309.

The animal study was reviewed and approved by the Animal Ethics Committee of the National Institute of Immunology, New Delhi, India.

AS and RA conceived the project. IK and AS designed all the experiments and analyzed the data. IK performed the experiments. RA, SB, and BS generated the reagents for the study. AQ helped in transcriptome data collection and manuscript editing. All authors contributed to the article and approved the submitted version.

The Plasmodium berghei strain ANKA, MRA-671, contributed by Mark F. Wiser, and strain (ANKA) 507m6cl1, MRA-867, contributed by Chris J. Janse and Andrew P. Waters, were obtained through BEI Resources, NIAID, NIH. This work was financially supported by Science and Engineering Research Board (SERB), Government of India grant (EMR/2015/001546) sanctioned to AS. IK received fellowships from National Institute of Immunology (NII) core grant and SERB, Government of India.

The Supplementary Figure 2 | Antibodies against the MSP1 stain the merozoites surface uniformly unlike PbTIP. Anti-MSP1 primary antibody staining (secondary antibody was labelled with Alexa 594) showed that MSP1 was present uniformly all over the merozoites surface while PbTIP expression was uneven on the merozoites surface. PbTIP is localized more at one end of the merozoites rather than distribution all over the surface as MSP1. Scale bar 1µm.

Supplementary Figure 3 | PbTIP is exported across the PV membrane and localized to the surface of host cells. Plasmodium PbTIP is exported out of PVM and become the part of erythrocytes membrane. Here, the PV membrane is marked in red by staining against the EXP1 protein (secondary antibody was labelled with Alexa 594) and PbTIP expression (green, secondary antibody with Alexa 488) is shown beyond it. Scale bar 5µm.

Supplementary Figure 4 | MSP1 is not shed from schizonts surface. MSP1 protein was used as a negative control to show shedding of PbTIP from the Plasmodium schizonts and other stages of parasite. PbTIP was shown to shed from various parasitic stages while MSP1 gives the typical staining on merozoites and schizonts. Scale bar 5µm.

Supplementary Figure 5 | Expression and purification of recombinant PbTIP in E. coli. (A) Inclusion bodies from IPTG induced bacterial pellet was solubilized in 8M urea buffer and protein recovered from inclusion bodies was refolded by step-wise removal of urea by dialysis. No precipitation was observed during dialysis and high purity (>95%) protein was recovered from inclusion bodies. Refolded protein was run on an acrylamide gel. Two lanes represent protein loading in duplicates. (B) Overexpressed recombinant PbTIP was confirmed with western blotting using antibodies against the GST and detected the full-length PbTIP along with GST at 95kDa (right panel). A major fragment was observed at~55kDa which is a cleaved fragment of the full-length PbTIP and explained below. Two lanes represent the protein loading in duplicates. Figure 6 | N-terminal sequence analysis of the~55kDa fragment recovered along with full-length recombinant PbTIP revealed one of the cleavage sites near its N-terminus. Inclusion bodies purified PbTIP was subjected to electrophoresis and transferred onto the PVDF membrane. After Ponceau staining PbTIP fragment~55kDa (TF55) was cut from the membrane and processed for Nterminal amino acid sequencing by Edman`s degradation method. The first 10 amino acids of this PbTIP fragment revealed a cleavage between128-129 amino acids position in the full-length protein. Figure 7 | Schizonts burst do not contribute to the shed PbTIP in the host circulation. Shedding of PbTIP from a gametocyte (FITC signal) while signals were not detected from the merozoites upon schizonts burst. These two independent events were captured in the same field suggesting that schizonts burst does not contribute significantly to shed PbTIP.

Supplementary Figure 8 | Pro-inflammatory and anti-inflammatory cytokines profile of LPS elicited RAW 264.7 cells upon exposure of recombinant PbTIP. RAW 264.7 cells were stimulated with LPS (100ng/ml) alone and LPS+recombinant PbTIP (10µg/ml) keeping the untreated cells as naïve. The level of various cytokines was measured in the culture medium (spent medium) by ELISA following the manufacturers protocol (Biolegend and BD). ELISA results indicate that PbTIP significantly suppressed the pro-inflammatory cytokines (IL-1b, TNF-a, IFN-g and IL-12p40) expression in LPS elicited macrophages in-vitro, suggesting immunosuppressive effect of PbTIP on macrophages. P-values for IL-1b, TNF-a, IFN-g and IL-12p40 respectively are 0.0017, 0.0032, 0.0203, and 0.0026. Proinflammatory cytokines were measured upon 9hours of stimulation. Antiinflammatory cytokines (IL-10 and TGF-b) were also measured by ELISA however upon longer incubation (20hours) and found to be significantly over-expressed in PbTIP exposed LPS-elicited macrophages. These results demonstrate the PbTIP potential to favour anti-inflammatory responses in macrophages while suppressing the pro-inflammatory responses. P-values for IL-10 and TGF-b respectively are 0.00504 and 0.0005. P-values were calculated by applying t-test.

Supplementary Figure 9 | Volcano plot displaying differentially expressed genes of PBMCs upon PbTIP treatment. The volcano plot displaying differentially expressed genes of mouse PBMCs upon treatment with PbTIP as described in (i).

Here the x-axis represents the log 2 fold change while the y-axis denotes -log 10 (qvalue) or -log 10 (false discovery rate). All significantly up-regulated/down-regulated genes are highlighted in red dots while genes that were validated by qPCR are in blue dots. Black dots denote non-significant genes in the study (adjusted -log 10 q-value<0.05). Most of the genes in the study were found to be up-regulated hence giving a skewed appearance to the volcano plot.

Supplementary Figure 10 | Transcriptome data validation by RT-qPCR. Primers were designed against the few genes that were significantly changed in the transcriptome data. Primers list is given in the Table S3 . RT-qPCR was performed on cDNA from RNA samples that were given for transcriptome analysis. The genes transcripts that were found up-regulated in transcriptome analysis were also found up-regulated when tested by qPCR.

Supplementary Figure 11 | Estimation of antibody titre of anti-PbTIP immune sera. Antibody titre of anti-PbTIP antibodies collected from recombinant PbTIP immunized mice, was estimated by ELISA. ELISA plate was coated with purified recombinant PbTIP and ELISA was performed as discussed earlier in the method section. OD370nm was plotted against different dilutions of immune sera. Antibodies against PbTIP were able to recognize antigen up to~0.25 million dilutions. Control immunized (sham-treated) mice were taken as a negative control in ELISA.

ISBN 978 92

EPIDEMIA-An EcoHealth Informatics System for Integrated Forecasting of Malaria Epidemics

Acquired Immunity to Malaria

Protection of Humans Against Malaria by Immunization With Radiation-Attenuated Plasmodium Falciparum Sporozoites

Induction of Proinflammatory Responses in Macrophages by the Glycosylphosphatidylinositols of Plasmodium Falciparum: Cell Signaling Receptors, Glycosylphosphatidylinositol (GPI) Structural Requirement, and Regulation of GPI Activity

Setting the Stage: The Initial Immune Response to Blood-Stage Parasites

Pure Hemozoin Is Inflammatory In Vivo and Activates the NALP3 Inflammasome via Release of Uric Acid

Toll-Like Receptor 9 Mediates Innate Immune Activation by the Malaria Pigment Hemozoin

Cytotoxic Activities of CD8+ T Cells Collaborate With Macrophages to Protect Against Blood-Stage Murine Malaria

Cytotoxic CD8 + T Cells Recognize and Kill Plasmodium vivax-Infected Reticulocytes

CD4+ T Cells and B Cells Are Necessary for the Transfer of Protective Immunity Toplasmodium Chabaudi Chabaudi

Escaping the Immune System: How the Malaria Parasite Makes Vaccine Development a Challenge

Plasmodium Falciparum-Infected Erythrocytes Modulate the Maturation of Dendritic Cells

Cutting Edge: The Acquisition of TLR Tolerance During Malaria Infection Impacts T Cell Activation

Systemic Activation of Dendritic Cells by Toll-Like Receptor Ligands or Malaria Infection Impairs Cross-Presentation and Antiviral Immunity A R T I C L E S

Chronic Exposure to Plasmodium Falciparum Is Associated With Phenotypic Evidence of B and T Cell Exhaustion

Apoptosis and Dysfunction of Blood Dendritic Cells in Patients With Falciparum and Vivax Malaria

PD-1 Dependent Exhaustion of CD8+ T Cells Drives Chronic Malaria

Escape of Malaria Parasites From Host Immunity Requires CD4 +CD25+ Regulatory T Cells

Human Cord Blood CD4 + CD25 Hi Regulatory T Cells Suppress Prenatally Acquired T Cell Responses to Plasmodium Falciparum Antigens

Integrative Approaches to Understand the Mastery in Manipulation of Host Cytokine Networks by Protozoan Parasites With Emphasis on Plasmodium and Leishmania Species

A Plasmodium-Encoded Cytokine Suppresses T-Cell Immunity During Malaria

Leishmania-Encoded Orthologs of Macrophage Migration Inhibitory Factor Regulate Host Immunity to Promote Parasite Persistence

Manipulation of Host-Cell Pathways by Bacterial Pathogens

Parasitic Nematode Immunomodulatory Strategies: Recent Advances and Perspectives. Pathogens

Helminth Immunoregulation: The Role of Parasite Secreted Proteins in Modulating Host Immunity

TIP, a T-Cell Factor Identified Using High-Throughput Screening Increases Survival in a Graft-Versus-Host Disease Model

A TIP on malaria ( genomics ) To the editor

SMART, a Simple Modular Architecture Research Tool: Identification of Signaling Domains

An Exoprotein Required for Filament Adhesion and Aggregation in. A Nabaena

Role of the Vibrio Cholerae Matrix Protein Bap1 in Cross-Resistance to Antimicrobial Peptides

A Functional Genomic Database for Malaria Parasites

Integrin-a FG-GAP Repeat-Containing Protein 2 Is Critical for Normal B Cell Differentiation and Controls Disease Development in a Lupus Model

Experimental Support for a-Propeller Domain in Integrin-Subunits and a Calcium Binding Site on its Lower Surface

How Pathogens Use Linear Motifs to Perturb Host Cell Networks

Predicting Transmembrane Protein Topology With a Hidden Markov Model: Application to Complete Genomes

Protein Export in Malaria Parasites: Do Multiple Export Motifs Add Up to Multiple Export Pathways?

Shedding of TRAP by a Rhomboid Protease From the Malaria Sporozoite Surface Is Essential for Gliding Motility and Sporozoite Infectivity

Two Plasmodium Rhomboid Proteases Preferentially Cleave Different Adhesins Implicated in All Invasive Stages of Malaria

LPS-Stimulated NF-kb P65 Dynamic Response Marks the Initiation of TNF Expression and Transition to IL-10 Expression in RAW

Negative Regulation of Melanoma Differentiation-Associated Gene 5 (MDA5)-Dependent Antiviral Innate Immune Responses by Arf-Like Protein 5b *

BTLA is a Lymphocyte Inhibitory Receptor With Similarities to CTLA-4 and PD-1

Loss of Atrx Sensitizes Cells to DNA Damaging Agents Through P53-Mediated Death Pathways

Human Monocytes Undergo Excessive Apoptosis Following Temozolomide Activating the ATM/ATR Pathway While Dendritic Cells and Macrophages Are Resistant

Amplification and Overexpression of CACNA1E Correlates With Relapse in Favorable Histology Wilms' Tumors

Cancer Therapy: Preclinical PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity

Mouse Macrophages Completely Lacking Rho Subfamily GTPases (RhoA, RhoB, and RhoC) Have Severe Lamellipodial Retraction Defects, But Robust Chemotactic Navigation and Altered Motility

Parasite Evasion Strategies and Their Relevance for "Macroscopic Phenomena

Correspondence: Dr E The War Between the Malaria Parasite and the Immune System: Immunity, Immunoregulation and Immunopathology

IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIA

As Novel Biotherapeutics Secreted Immunomodulatory Viral Proteins

Immunerfstimimicry in Malaria: Plasmodium Falciparum Secretes a Functional Histamine-Releasing Factor Homolog In Vitro and In Vivo

LINKIN, a New Transmembrane Protein Necessary for Cell Adhesion

Secondary Processing of the Plasmodium Falciparum Merozoite Surface Protein-1 (MSP1) by a Calcium-Dependent Membrane-Bound Serine Protease: Shedding of MSP133 as a Noncovalently Associated Complex With Other Fragments of the MSP1

A Single Malaria Merozoite Serine Protease Mediates Shedding of Multiple Surface Proteins by Juxtamembrane Cleavage

Malaria Sporozoites Release Circumsporozoite Protein From Their Apical End and Translocate It Along Their Surface

Intriguing Parasites and Intramembrane Proteases

Substrate Specificity of Rhomboid Intramembrane Proteases Is Governed by Helix-Breaking Residues in the Substrate Transmembrane Domain

Rapid Diagnostic Tests for Malaria

EmTIP, a T-Cell Immunomodulatory Protein Secreted by the Tapeworm Echinococcus Multilocularis Is Important for Early Metacestode Development

IL-10 From CD4 + CD25 2 Foxp3 2 CD127 2 Adaptive Regulatory T Cells Modulates Parasite Clearance and Pathology During Malaria Infection

Inducible Mechanisms of Disease Tolerance Provide an Alternative Strategy of Acquired Immunity to Malaria

Plasmodium Falciparum Malaria Drives Epigenetic Reprogramming of Human Monocytes Toward a Regulatory Phenotype

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.